Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 12/20 | 0.42 |
| ▸ | CTSL | P07711 | 4/20 | 0.35 |
| ▸ | CTSB | P07858 | 4/20 | 0.35 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CTSH | P09668 | 1/20 | 0.34 |
| ▸ | CTSC | P53634 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6461829 | 0.93 | CTSS (0.43) | CTSSCTSLCTSBCTSKKDM4E | |
| SCHEMBL6463182 | 0.92 | CTSS (0.43) | CTSSCTSLCTSBCTSKKDM4E | |
| SCHEMBL7043169 | 0.91 | CTSS (0.44) | CTSSCTSLCTSBCTSKKDM4E | |
| SCHEMBL7114795 | 0.89 | LMNA (0.35) | CTSSKDM4EALDH1A1 | |
| SCHEMBL6464590 | 0.87 | CTSS (0.35) | CTSSKDM4EALDH1A1 | |
| SCHEMBL6462678 | 0.86 | CTSS (0.40) | CTSSCTSLCTSBCTSKKDM4E | |
| SCHEMBL7046391 | 0.86 | FAAH (0.37) | CTSSKDM4EFAAHCES1DAGLA | |
| SCHEMBL7045520 | 0.85 | FAAH (0.36) | CTSSCTSKFAAHCES1DAGLA | |
| SCHEMBL6468761 | 0.85 | CTSS (0.40) | CTSSCTSLCTSBCTSKCTSH | |
| SCHEMBL7044830 | 0.85 | CTSS (0.40) | CTSSCTSLCTSBCTSKCTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1694357-A1 | USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC | AXYS PHARMACEUTICALS, INC. (US) | 2006-08-30 | — | — | EP | disclosed |
| WO-2005058348-A1 | USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC | AXYS PHARMACEUTICALS, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| US-6576630-B1 | Alkanoyl substituted benzooxazoles or naphthooxazoles | AXYS PHARMACEUTICALS, INC. | 2003-06-10 | — | — | US | disclosed |